Decoding the Dimorphic Trap: Prioritizing B12 Before Iron in India's Severe Anaemia Protocols

Dr. Riti Agarwal

Decoding the Dimorphic Trap: Prioritizing B12 Before Iron in India's Severe Anaemia Protocols

Author(s)	Dr. Riti Agarwal
Country	India
Abstract	Background and Context: Anaemia remains a monumental public health crisis in India, characterized not just by isolated iron depletion, but by a complex overlap of multiple micronutrient deficiencies. Dimorphic anaemia—the simultaneous presence of iron deficiency and megaloblastic anaemia (primarily driven by Vitamin B12 and folate deficiencies)—presents a unique clinical challenge. Given the high prevalence of vegetarianism and gastrointestinal malabsorption in India, severe B12 deficiency is frequently masked by concurrent iron deficiency. Objective Statement: This article aims to evaluate the systemic risks of traditional iron-first therapeutic approaches and proposes a robust, case-based protocol prioritizing Vitamin B12 replacement before or alongside iron therapy in the management of severe dimorphic anaemia in the Indian context. Methodology Summary: A systematic review of epidemiological data, hematological protocols, and public health guidelines spanning 2020 to 2026 was conducted. The analysis framework evaluated biological mechanisms of erythropoiesis, current policy interventions like the Anemia Mukt Bharat (AMB) 7×7×7 strategy, and the sociocultural determinants of Indian diets. Key Findings: ● The Masked MCV Phenomenon: Concurrent microcytosis (from low iron) and macrocytosis (from low B12) often normalize the Mean Corpuscular Volume (MCV), leading to misdiagnosis if Red Cell Distribution Width (RDW) is ignored. ● Neurological Jeopardy: Initiating aggressive iron therapy (especially intravenous) in a B12-depleted patient accelerates erythropoiesis, instantly depleting residual B12 stores. This can precipitate Subacute Combined Degeneration (SACD) of the spinal cord, leading to irreversible neuropathy. ● Hypokalemia Risk: Rapid red blood cell production induced by iron, without B12 stabilization, can trigger severe, life-threatening intracellular potassium shifts. Conclusions and Recommendations: The traditional paradigm of treating all severe anaemias reflexively with high-dose Iron Folic Acid (IFA) must be revised. A mandatory "B12-first" or simultaneous administration protocol is critical for Indian healthcare settings, particularly in primary and secondary care tiers.
Keywords	Dimorphic Anaemia, Vitamin B12 Deficiency, Subacute Combined Degeneration, Iron Replacement, Anemia Mukt Bharat, Erythropoiesis, Indian Healthcare.
Field	Medical / Pharmacy
Published In	Volume 17, Issue 4, October-December 2026
Published On	2026-10-12

View / Download PDF File

About IJSAT Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics	Join as a Reviewer Editors & Reviewers Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us	Message on WhatsApp	+91-9687-182-185	editor@ijsat.org

International Journal on Science and Technology

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Decoding the Dimorphic Trap: Prioritizing B12 Before Iron in India's Severe Anaemia Protocols

Share this